World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
21978
World Ranking
1281
National Ranking
567

Medicine

D-Index
79
Citations
23169
World Ranking
17551
National Ranking
8780

Overview

Olaf Stüve is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research primarily focuses on medicine, with significant contributions to the fields of pathology and forensic medicine, immunology, neurology, oncology, and genetics.

The scientist's work covers various topics, including:

  • Multiple Sclerosis Research Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Immunotherapy and Immune Responses
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Polyomavirus and related diseases
  • Chronic Myeloid Leukemia Treatments

Among Olaf Stüve's recent publications are:

  • "Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome," 2022, Annals of Neurology
  • "Toward Precision Phenotyping of Multiple Sclerosis," 2022, Neurology Neuroimmunology & Neuroinflammation
  • "Choroid plexus volumetrics and brain inflammation in multiple sclerosis," 2021, Proceedings of the National Academy of Sciences
  • "Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database," 2020, Multiple Sclerosis Journal
  • "Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials," 2024, The Lancet Neurology

Frequent coauthors include Navid Manouchehri, Afsaneh Shirani, Anne H. Cross, Rehana Z. Hussain, and Nil Saez-Calveras. Collaboration with these researchers reflects a consistent engagement in studies related to neurological and immunological conditions.

Olaf Stüve's publications appear often in venues such as:

  • Therapeutic Advances in Neurological Disorders
  • Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Proceedings of the National Academy of Sciences
  • Multiple Sclerosis Journal

Best Publications

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

    Sawsan Youssef;Olaf Stüve;Juan C. Patarroyo;Pedro J. Ruiz;Pedro J. Ruiz

  • The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

    Ruth Ann M Marrie;Stephen Reingold;Jeffrey A Cohen;Olaf Stuve

  • Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

    Martin S Weber;Thomas Prod'homme;Sawsan Youssef;Shannon E Dunn

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • Interferon beta in the treatment of multiple sclerosis Mechanisms of action

    V. Wee Yong;Sophie Chabot;Olaf Stuve;Gary Williams

  • Acute disseminated encephalomyelitis: an update.

    Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl

  • A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview

    Ruth Ann M Marrie;Jeffrey A Cohen;Olaf Stuve;Maria Trojano

  • Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9

    Olaf Stüve;Nora P. Dooley;Joon H. Uhm;Jack P. Antel

  • Factors that influence adherence with disease-modifying therapy in MS.

    Katherine Treadaway;Gary Cutter;Amber Salter;Sharon Lynch

  • Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

    Olaf Stüve;Christina M. Marra;Amit Bar-Or;Masaaki Niino

  • Treatment of neuromyelitis optica: Review and recommendations

    Dorlan J. Kimbrough;Kazuo Fujihara;Anu Jacob;Marco A. Lana-Peixoto

  • Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

    R. Zivadinov;A. T. Reder;M. Filippi;A. Minagar

  • Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

    Krzysztof Selmaj;David K B Li;Hans Peter Hartung;Bernhard Hemmer

  • The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors

    Johann Sellner;Jörg Kraus;Amer Awad;Ron Milo

  • The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

    Martin Stangel;Sten Fredrikson;Edgar Meinl;Axel Petzold;Axel Petzold

  • Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

    H. Openshaw;O. Stuve;J.P. Antel;R. Nash

  • Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis

    Olaf Stuve;Sabine Cepok;Birte Elias;Andreas Saleh

  • Optical coherence tomography in multiple sclerosis.

    Elliot Frohman;Fiona Costello;Robert Zivadinov;Olaf Stuve;Olaf Stuve

  • A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

    Ruth Ann Marrie;Nadia Reider;Jeffrey Cohen;Olaf Stuve

  • Statins as potential therapeutic agents in neuroinflammatory disorders.

    Olaf Stüve;Sawsan Youssef;Lawrence Steinman;Scott S. Zamvil

Frequent Co-Authors

Bernd C. Kieseier
Bernd C. Kieseier Novartis (Switzerland)
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Elliot M. Frohman
Elliot M. Frohman The University of Texas at Austin
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Michael K. Racke
Michael K. Racke Quest Diagnostics (United States)
Scott S. Zamvil
Scott S. Zamvil University of California, San Francisco
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Lawrence Steinman
Lawrence Steinman Stanford University
Heinz Wiendl
Heinz Wiendl University of Münster
Robert Zivadinov
Robert Zivadinov University at Buffalo, State University of New York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring complementary fields can expand career opportunities. Health information management is a growing sector, and pursuing an accredited online health information management degree cahiim can provide essential skills to manage and analyze health data effectively.

For those looking for quicker certification options, the healthcare industry offers valuable credentials like medical billing and coding. Many students opt for the best fastest online medical billing and coding certificate programs, which prepare graduates for essential administrative roles within medical labs and clinics.

Additionally, aspiring healthcare professionals can explore a range of medical degrees online that pay well, a flexible route for those balancing education with other commitments. These degrees open doors to high-demand jobs such as nursing, public health, and clinical research.

Public health is closely linked to microbiology, and earning a Master of Public Health (MPH) can enhance career prospects. Selecting from accredited online mph programs easy to get into allows students to enter or advance in this vital field with fewer barriers to entry.

Best Scientists Citing Olaf Stüve

Trending Scientists

Recently Published Articles